Search

everythinglearnresearchcommunity

for

Search:↓

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Researchers created a lab model to study human hair growth, showing it can grow and self-regulate outside the body.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

The enzyme sEH is important for hair growth and its inhibition could help treat hair loss.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

TGF-β2 plays a key role in human hair growth and development.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Different races and genders have unique skin and hair issues, requiring specialized care and more research for effective treatment.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Women with PCOS are much more likely to have sleep problems and should be checked for them.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Dextran sulfate was found to be toxic and ineffective for treating HIV.

Stem cells in the hair follicle are regulated by their surrounding environment, which is important for hair growth.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Advanced hydrogel systems with therapeutic agents could greatly improve acute and chronic wound treatment.

DHT, a testosterone byproduct, causes male pattern baldness.

Using psychological treatments can help manage skin conditions along with regular medical care.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Stem cells and their surrounding environment in hair follicles work closely together, affecting hair growth and having implications for cancer and tissue regeneration.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.